Novel Hits for N-Myristoyltransferase Inhibition Discovered by Docking-Based Screening

N-myristoyltransferase (NMT) inhibitors that were initially developed for treatment of parasitic protozoan infections, including sleeping sickness, malaria, and leismaniasis, have also shown great promise as treatment for oncological diseases. The successful transition of NMT inhibitors, which are c...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Danislav S. Spassov, Mariyana Atanasova, Irini Doytchinova
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/17/5478